Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus. | ||
Ibn Al-Haitham Journal For Pure And Applied Science | ||
Article 1, Volume 30, Issue 2, December 2017, Pages 100-111 | ||
Authors | ||
Ahmed A. Lazim; Muntaha A. Lafta | ||
Abstract | ||
The glucagon-like peptide-1 is secreted by intestinal L cells in response to nutrient ingestion. It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels , additionally, glucagon-like peptide-1 delays gastric emptying and suppresses appetite. The impaired secretion of glucagon-like peptide-1 has negative influence on hyperlipidemia, diabetes and insulin resistance related diseases the levels of its secretion change with the intake of different nutrients. Some drugs also have influence on GLP-1 secretion . | ||
Keywords | ||
Hyperlipidemia; glucagon like peptide; GLP | ||
Statistics Article View: 131 PDF Download: 33 |